Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Cua

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
American Journal of Men'S Health|March 2, 2019
Pleasure and PrEP: Pleasure-Seeking Plays a Role in Prevention Choices and Could Lead to PrEP InitiationXavier Mabire, Costanza Puppo, Stéphane Morel, et al.
The Journal of Infectious Diseases|February 28, 2002
Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferationPierre-Marie Roger, Jean-Philippe Breittmayer, Jacques Durant, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|May 31, 2019
Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination PreventionCostanza Puppo, Xavier Mabire, Laurent Cotte, et al.
Open Forum Infectious Diseases|December 13, 2018
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY TrialMarie-Laure Chaix, Isabelle Charreau, Claire Pintado, et al.
The Journal of Infectious Diseases|July 2, 2017
Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis ProgramsConstance Delaugerre, Guillemette Antoni, Nadia Mahjoub, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infectionAlice-Andrée Mariaggi, Rebecca Bauer, Caroline Charre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2021
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trialLauriane Goldwirt, Rebecca Bauer, Geoffroy Liegeon, et al.
AIDS (London, England)|December 3, 2019
Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxisJulien Gras, Nadia Mahjoub, Isabelle Charreau, et al.
The Lancet. HIV|December 1, 2019
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trialGuillemette Antoni, Cécile Tremblay, Constance Delaugerre, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
American Journal of Men'S Health|March 2, 2019
Pleasure and PrEP: Pleasure-Seeking Plays a Role in Prevention Choices and Could Lead to PrEP InitiationXavier Mabire, Costanza Puppo, Stéphane Morel, et al.
The Journal of Infectious Diseases|February 28, 2002
Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferationPierre-Marie Roger, Jean-Philippe Breittmayer, Jacques Durant, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|May 31, 2019
Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination PreventionCostanza Puppo, Xavier Mabire, Laurent Cotte, et al.
Open Forum Infectious Diseases|December 13, 2018
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY TrialMarie-Laure Chaix, Isabelle Charreau, Claire Pintado, et al.
The Journal of Infectious Diseases|July 2, 2017
Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis ProgramsConstance Delaugerre, Guillemette Antoni, Nadia Mahjoub, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
HIV-1-RNA and total HIV-1-DNA loads in the genital compartment in men receiving dolutegravir- versus darunavir-based combined ART (cART) regimens during primary HIV infectionAlice-Andrée Mariaggi, Rebecca Bauer, Caroline Charre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2018
Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with menLaurent Cotte, Eric Cua, Jacques Reynes, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2021
Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trialLauriane Goldwirt, Rebecca Bauer, Geoffroy Liegeon, et al.
AIDS (London, England)|December 3, 2019
Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxisJulien Gras, Nadia Mahjoub, Isabelle Charreau, et al.
The Lancet. HIV|December 1, 2019
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trialGuillemette Antoni, Cécile Tremblay, Constance Delaugerre, et al.
Pageof 5